Why Is CytomX (CTMX) Stock Down 43% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

CytomX Therapeutics stock is falling hard on Thursday after the company posted lackluster results in a cancer treatment clinical trial update.

The post Why Is CytomX (CTMX) Stock Down 43% Today? appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• It doesn’t matter if you have $500 or $5 million. Do this now.